Fluorescent 6-amino-6-deoxyglycoconjugates for glucose transporter mediated bioimaging.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2016-11-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbrc.2016.10.045PMID 27765631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer.

  2016cited by this paper
• Cyanine-based 1-amino-1-deoxyglucose as fluorescent probes for glucose transporter mediated bioimaging.

  2016cited by this paper
• Methyl 6‐Amino‐6‐deoxy‐d‐pyranoside‐Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)‐Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism

  2016cited by this paper
• Impact of molecular charge on GLUT-specific cellular uptake of glucose bioprobes and in vivo application of the glucose bioprobe, GB2-Cy3.

  2014cited by this paper
• The mechanism of different sensitivity of meso-substituted and unsubstituted cyanine dyes in rotation-restricted environments for biomedical imaging applications

  2014cited by this paper
• Bioprobes based on AIE fluorogens.

  2013cited by this paper
• Exploiting the mechanism of cellular glucose uptake to develop an image-based high-throughput screening system in living cells.

  2013cited by this paper
• Visualizing Sweetness: Increasingly Diverse Applications for Fluorescent-Tagged Glucose Bioprobes and Their Recent Structural Modifications

  2012cited by this paper
• Development of fluorescent glucose bioprobes and their application on real-time and quantitative monitoring of glucose uptake in living cells.

  2011cited by this paper
• Structural and molecular biology of type I galactosemia: Disease‐associated mutations

  2011cited by this paper
• High 18F-FDG Uptake in Microscopic Peritoneal Tumors Requires Physiologic Hypoxia

  2010cited by this paper
• Stability of N-glycan profiles in human plasma.

  2009cited by this paper
• Development of a cy3-labeled glucose bioprobe and its application in bioimaging and screening for anticancer agents.

  2007cited by this paper
• A real-time method of imaging glucose uptake in single, living mammalian cells

  2007cited by this paper
• Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.

  2006cited by this paper
• Uptake of a Fluorescent Deoxyglucose Analog (2-NBDG) in Tumor Cells

  2005cited by this paper
• Platinum‐based anticancer agents: Innovative design strategies and biological perspectives

  2003cited by this paper
• Functional analysis of disease-causing mutations in human galactokinase.

  2003cited by this paper
• Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose‐binding site of the human erythrocyte glucose transporter GLUT1

  2003cited by this paper
• A convenient preparation of several N-linked glycoamino acid building blocks for efficient solid-phase synthesis of glycopeptides

  2002cited by this paper
• Flavonoid Inhibition of Sodium-dependent Vitamin C Transporter 1 (SVCT1) and Glucose Transporter Isoform 2 (GLUT2), Intestinal Transporters for Vitamin C and Glucose*

  2002cited by this paper
• Intracellular accumulation of ascorbic acid is inhibited by flavonoids via blocking of dehydroascorbic acid and ascorbic acid uptakes in HL-60, U937 and Jurkat cells.

  2000cited by this paper
• Glucose uptake rates of single E. coli cells grown in glucose-limited chemostat cultures.

  2000cited by this paper
• Measurement of Glucose Uptake and Intracellular Calcium Concentration in Single, Living Pancreatic β-Cells*

  2000cited by this paper
• Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras.

  2000cited by this paper
• Examining glucose transport in single vascular smooth muscle cells with a fluorescent glucose analog.

  1999cited by this paper
• Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database

  1999cited by this paper
• The fundamental importance of human galactose metabolism: lessons from genetics and biochemistry.

  1998cited by this paper
• NEW GLYCOCONJUGATED CYANINE DYES AS FLUORESCENT LABELING REAGENTS

  1998cited by this paper
• Identification of an Amino Acid Residue That Lies between the Exofacial Vestibule and Exofacial Substrate-binding Site of the Glut1 Sugar Permeation Pathway*

  1997cited by this paper
• A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli.

  1996cited by this paper
• Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells.

  1996cited by this paper
• Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus.

  1995cited by this paper
• Cyanine dye labeling reagents: sulfoindocyanine succinimidyl esters.

  1993cited by this paper
• Asymmetric transport of a fluorescent glucose analogue by human erythrocytes.

  1985cited by this paper
• Quercetin inhibits hexose transport in a human diploid fibroblast

  1978cited by this paper
• Structural requirements for binding to the sugar-transport system of the human erythrocyte.

  1973cited by this paper
• The FASEB Journal • Research Communication Inhibition of the intestinal glucose transporter GLUT2 by flavonoids

  year unknowncited by this paper

• Navigating Solute Carrier Transporters—A Comprehensive Review of Functionalized Small Molecule Probes for Target Identification and Characterization

  2025cites this paper
• Post-click labeling enables highly accurate single cell analyses of glucose uptake ex vivo and in vivo

  2024cites this paper
• Bioimaging of glucose analogs labeled at the C-1 or C-2 position with a fluorescent dansylamino group.

  2023cites this paper
• Glucose conjugated aza-BODIPY for enhanced photodynamic cancer therapy.

  2021cites this paper
• Near-IR Fluorescent Tracer for Glucose-Uptake Monitoring in Live Cells.

  2018cites this paper